Skip to main content
. 2022 Apr 21;192(2):549–560. doi: 10.1007/s11845-022-03008-8

Table 2.

Recurrence surgery group

Paper N= surgery Recurrence (%) Site of recurrence
(Abdo-wall/intra-abdominal)
R0 [R1/R2] Post-op. morbidity Post-op. mortality Mean follow-up [median/IQR]
Mussi et al. [6] 30 3 (10%) [3/0] 24 [3] 3 0 42/1–49
Burtenshaw et al. [7] 67 16 (23.8%) [2/14] 14 [2] N.S N.S [22/8–220]
Turner et al. [28] 25 1 (4%) [0/1] 5 [8] N.S N.S [35/1–137]
Yabanoglu et al. [29] 13 3 (23.1%) [3/0] 11 [2] 0 0 56.7 [3–177]
Smith et al. [30] 16 6 (37.5%) [0/6] 3 [11] 8 1 [62/N.S]
Bonvalot et al. [16] 41 1 (2.4%) [1/0] 23 [0] 0 0 [97/9–226]
Wilkinson et al. [15] 50 4 (8%) [4/0] 22 [28] 2 0 [6/12–180]
Stojadinovic et al. [32] 39 3 (7.6%) [3/0] 28 [11] 4 0 [53/4–212]
Wilkinson et al. [33] 15 2 (13.3%) [2/0] 2 [13] 1 0 [40/6–119]
Bertani et al. [20] 14 0 (0%) [0/0] 13 [0] 0 0 48.8 [55/11–108]
Desurmont et al. [34] 17 3 (17.6%) [0/3] 6 (N.S) 0 2 89.4 ± 76.2 [72.6/1.7–280]
Netto et al. [35] 27 3 (11.1%) [3/0] 21 [6] 8 0 82 [N.S]
Zenzri et al. [36] 27 11 (40.7%) N.S 14 [13] N.S N.S [21/1–60]
Kumar et al. [37] 22 8 (36.3%) [8/0] 16 [6] N.S N.S N.S/range 12–120
Yalav et al. [38] 11 1 (9.1%) [0/1] 10 [1] 0 1 43.4 ± 28.4
Pencavel et al. [39] 30 0 (0%) [0/0] 15 [15] 1 0 [39.2/7–107]
Crago et al. [40] 171 31 (18.1%) [8/23] 57 [43] N.S 6 [60/0–327]
Xiao et al. [41] 11 1 (9.1%) [0/1] 10 [1] N.S N.S 23/range 4–72
Walter et al. [42] 36 26 (72.2%) [0/20] N.S N.S N.S [108/1.2–372]
Wheeler et al. [44] 18 0 (0%) [0/0] N.S 1 4 [27/1–161]
Lahat et al. [45] 16 0 (0%) [0/0] 15 [1] 5 0 [64/5–143]
696 123 (17.7%) (37/68) R0 = 309 33 (4.7%) 14 (2%) 55.04 [50.7/1–372]
Recurrence post-secondary resection
Paper N = surgery Recurrence (%) Site of recurrence (A/B) R0 [R1] Post-op morb Post-op mort Mean follow-up [median/IQR]
Cates [31] 29 9 (31.1%) N.S 3 [5] N.S N.S [43.2/2.5–267.6]
Smith et al. [30] 4 1 (25%) [0/1] N.S 0 1 [62/N.S]
Burtenshaw et al. [7] 3 0 (0%) N.S [9] N.S N.S [17/8–19]
Bonvalot et al. [16] 2 0 (0%) N.S N.S N.S 0 [97/9–226]
Kumar et al. [37] 8 3 (37.5%) N.S N.S N.S N.S N.S [12–120]
Zenzri et al. [36] 3 1 (33.3%) N.S 0 [3] N.S N.S [21/1–60]
Stojadinovic et al. [32] 2 2 (100%) [2/0] 0 [2] N.S 0 [53/4–212]
Netto et al. [35] 1 1 (100%) [1/0] 0 [1] N.S N.S 82 [N.S]
Xiao et al. [41] 1 1 (100%) [0/1] N.S N.S N.S 23/[4–72]
53 18 (34%) [3/2] R0 = 3 0 1 (1.9%) 52.5 [48.9/1–267.6]